ESOPJun 17, 2026, 04:12 PM
ImageneBio Stockholders Approve 850,000 Share Increase to Equity Plan
AI Summary
ImageneBio, Inc. held its 2026 Annual Meeting of Stockholders on June 16, 2026, where shareholders approved an amendment to the 2025 Equity Incentive Plan. This amendment increases the aggregate number of shares authorized for issuance under the plan by 850,000 shares and modifies the calculation for the annual automatic share reserve increase. Additionally, stockholders elected two Class II directors, David P. Bonita, M.D. and Joseph P. Slattery, and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2026.
Key Highlights
- Stockholders approved an amendment to the 2025 Equity Incentive Plan.
- The plan's authorized share issuance increased by 850,000 shares.
- Annual automatic share reserve increase calculation now includes convertible preferred stock and prefunded warrants.
- David P. Bonita, M.D. and Joseph P. Slattery were elected as Class II directors.
- PricewaterhouseCoopers LLP was ratified as the independent auditor for fiscal year 2026.
- The Amended Plan was approved with 6,322,909 votes For.
Price Impact
More from IMA